ImmuCell PE Ratio 2012-2025 | ICCC
Current and historical p/e ratio for ImmuCell (ICCC) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ImmuCell PE ratio as of February 10, 2026 is 25.50.
| ImmuCell PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-02-10 | 6.63 | 25.50 | |
| 2025-09-30 | 6.25 | $0.26 | 24.04 |
| 2025-06-30 | 6.96 | $0.19 | 36.63 |
| 2025-03-31 | 4.79 | $-0.07 | 0.00 |
| 2024-12-31 | 5.15 | $-0.29 | 0.00 |
| 2024-09-30 | 3.63 | $-0.50 | 0.00 |
| 2024-06-30 | 4.85 | $-0.53 | 0.00 |
| 2024-03-31 | 5.30 | $-0.51 | 0.00 |
| 2023-12-31 | 5.09 | $-0.75 | 0.00 |
| 2023-09-30 | 5.34 | $-0.82 | 0.00 |
| 2023-06-30 | 5.00 | $-0.78 | 0.00 |
| 2023-03-31 | 5.16 | $-0.69 | 0.00 |
| 2022-12-31 | 6.10 | $-0.30 | 0.00 |
| 2022-09-30 | 7.48 | $-0.07 | 0.00 |
| 2022-06-30 | 8.69 | $0.03 | 289.67 |
| 2022-03-31 | 9.65 | $0.14 | 68.93 |
| 2021-12-31 | 8.00 | $-0.01 | 0.00 |
| 2021-09-30 | 9.36 | $0.01 | 935.99 |
| 2021-06-30 | 9.50 | $-0.05 | 0.00 |
| 2021-03-31 | 9.64 | $-0.18 | 0.00 |
| 2020-12-31 | 5.95 | $-0.14 | 0.00 |
| 2020-09-30 | 5.43 | $-0.23 | 0.00 |
| 2020-06-30 | 4.73 | $-0.26 | 0.00 |
| 2020-03-31 | 3.79 | $-0.24 | 0.00 |
| 2019-12-31 | 5.15 | $-0.19 | 0.00 |
| 2019-09-30 | 5.57 | $-0.32 | 0.00 |
| 2019-06-30 | 6.50 | $-0.30 | 0.00 |
| 2019-03-31 | 6.35 | $-0.36 | 0.00 |
| 2018-12-31 | 7.05 | $-0.43 | 0.00 |
| 2018-09-30 | 8.33 | $-0.28 | 0.00 |
| 2018-06-30 | 6.82 | $-0.30 | 0.00 |
| 2018-03-31 | 7.00 | $-0.20 | 0.00 |
| 2017-12-31 | 8.79 | $-0.04 | 0.00 |
| 2017-09-30 | 6.50 | $0.01 | 0.00 |
| 2017-06-30 | 7.33 | $0.09 | 81.44 |
| 2017-03-31 | 5.53 | $0.14 | 39.50 |
| 2016-12-31 | 5.95 | $0.13 | 45.77 |
| 2016-09-30 | 7.73 | $0.21 | 36.81 |
| 2016-06-30 | 6.90 | $0.31 | 22.26 |
| 2016-03-31 | 6.85 | $0.34 | 20.15 |
| 2015-12-31 | 7.54 | $0.38 | 19.84 |
| 2015-09-30 | 5.95 | $0.33 | 18.03 |
| 2015-06-30 | 7.85 | $0.22 | 35.68 |
| 2015-03-31 | 6.29 | $0.09 | 69.86 |
| 2014-12-31 | 4.86 | $-0.06 | 0.00 |
| 2014-09-30 | 4.97 | $-0.15 | 0.00 |
| 2014-06-30 | 4.40 | $-0.13 | 0.00 |
| 2014-03-31 | 4.80 | $-0.03 | 0.00 |
| 2013-12-31 | 4.27 | $0.04 | 106.73 |
| 2013-09-30 | 4.73 | $0.08 | 59.13 |
| 2013-06-30 | 3.76 | $0.04 | 94.00 |
| 2013-03-31 | 3.68 | $0.04 | 92.00 |
| 2012-12-31 | 4.00 | $0.02 | 200.01 |
| 2012-09-30 | 5.11 | $0.03 | 170.33 |
| 2012-06-30 | 5.85 | $0.01 | 585.00 |
| 2012-03-31 | 5.42 | $-0.08 | 0.00 |
| 2011-12-31 | 4.65 | $-0.12 | 0.00 |
| 2011-09-30 | 5.30 | $-0.08 | 0.00 |
| 2011-06-30 | 7.90 | $-0.11 | 0.00 |
| 2011-03-31 | 3.43 | $-0.02 | 0.00 |
| 2010-12-31 | 3.20 | $-0.05 | 0.00 |
| 2010-09-30 | 3.20 | $-0.10 | 0.00 |
| 2010-06-30 | 3.37 | $-0.04 | 0.00 |
| 2010-03-31 | 3.51 | $-0.09 | 0.00 |
| 2009-12-31 | 3.71 | $-0.08 | 0.00 |
| 2009-09-30 | 3.58 | $-0.08 | 0.00 |
| 2009-06-30 | 2.48 | $-0.16 | 0.00 |
| 2009-03-31 | 1.90 | $-0.19 | 0.00 |
| 2008-12-31 | 1.66 | $-0.15 | 0.00 |
| 2008-09-30 | 3.18 | $-0.12 | 0.00 |
| 2008-06-30 | 3.47 | $0.09 | 38.56 |
| 2008-03-31 | 3.44 | $0.15 | 22.92 |
| 2007-12-31 | 3.55 | $0.22 | 16.14 |
| 2007-09-30 | 4.30 | $0.25 | 17.20 |
| 2007-06-30 | 5.99 | $0.19 | 31.53 |
| 2007-03-31 | 5.43 | $0.22 | 24.68 |
| 2006-12-31 | 5.95 | $0.22 | 27.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.060B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.241B | 21.80 |
| EssilorLuxottica (ESLOY) | France | $138.190B | 0.00 |
| Stryker (SYK) | United States | $138.078B | 26.49 |
| Medtronic (MDT) | Ireland | $130.022B | 18.01 |
| Boston Scientific (BSX) | United States | $110.071B | 24.34 |
| Medline (MDLN) | United States | $59.498B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.159B | 0.00 |
| ResMed (RMD) | United States | $38.392B | 25.64 |
| Agilent Technologies (A) | United States | $36.486B | 23.12 |
| GE HealthCare Technologies (GEHC) | United States | $36.105B | 17.30 |
| Koninklijke Philips (PHG) | Netherlands | $31.690B | 18.81 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.114B | 11.15 |
| Insulet (PODD) | United States | $17.756B | 55.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.032B | 0.00 |
| Baxter (BAX) | United States | $11.278B | 9.10 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.091B | 29.09 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.961B | 25.14 |
| Lantheus Holdings (LNTH) | United States | $4.454B | 13.57 |
| BillionToOne (BLLN) | United States | $4.208B | 0.00 |
| ICU Medical (ICUI) | United States | $3.782B | 24.02 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.128B | 14.76 |
| Haemonetics (HAE) | United States | $2.763B | 12.09 |
| Neogen (NEOG) | United States | $2.334B | 51.10 |
| Phibro Animal Health (PAHC) | United States | $2.097B | 18.48 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 40.17 |
| QuidelOrtho (QDEL) | United States | $1.984B | 12.76 |
| Perrigo (PRGO) | Ireland | $1.980B | 4.96 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.593B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Green Thumb Industries (GTBIF) | United States | $1.423B | 62.36 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.325B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.126B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.091B | 323.57 |
| InMode (INMD) | Israel | $0.924B | 10.15 |
| Tilray Brands (TLRY) | Canada | $0.912B | 0.00 |
| Valneva SE (VALN) | France | $0.846B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.792B | 0.00 |
| CeriBell (CBLL) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 14.15 |
| Brainsway (BWAY) | Israel | $0.457B | 77.83 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.428B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.368B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.12 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.288B | 0.00 |
| Quanterix (QTRX) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 18.54 |
| Aurora Cannabis (ACB) | Canada | $0.202B | 59.33 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.166B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.101B | 4.42 |
| Exagen (XGN) | United States | $0.079B | 0.00 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.92 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.56 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |